🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

4 Capsule(s) Serving Size
30 Servings
Other Combinations Product Type
25% Evidence Coverage

Supplement Facts — Evidence Check

ZMA
2400 mg
Tribulus terrestris extract
750 mg
GABA
50 mg
1 mg
📊 Market median: 3.0mg (984 products) 📚 236 studies (Tier A: 2, B: 109)
This product: 1mg UL 10mg

Other Ingredients

Millet Flour Silicon Dioxide Magnesium Stearate Vegetable Gelatin

Label Claims — Verification

All Other
Structure/Function
All Other (100% of products) Structure/Function (86% of products) Nutrient (7% of products)

Target Groups

Adult Male (18-50 Years) Gluten Free

Product Information

📋 Directions for Use

SUGGESTED USE: Take one serving (four capsules) COR-Performance(TM) ZMA(R) per day, 30-60 minutes before bedtime. For best results, avoid taking with dairy or other calcium-containing foods or supplements.

⚠️ Warnings & Precautions

WARNING: This product is only intended for use by healthy adult men, 18 years of age or older.

This product is not for use by women, particularly those who are pregnant or nursing.

Do not use this product if you have a serious medical condition.

Consult your physician or health care professional before using this product, if you have or suspect you have any medical condition including but not limited to an auto-immune condition, a depressive disorder, a sleep condition, high or low blood pressure or diabetes.

Do not take this product if you are currently taking any prescription or over-the-counter medication including sedatives or other CNS depressants, corticosteroids, immunosuppressants, anti-coagulants or medications to treat diabetes or high or low blood pressure.

Do not take this product in combination with alcoholic beverages. This product contains ingredients which may cause drowsiness. Do not operate a vehicle or heavy machinery following consumption of this product. Discontinue use and call a health care professional immediately if you experience any adverse reaction to taking this product. Follow label instructions and do not exceed recommendations for Suggested Use.

KEEP OUT OF REACH OF CHILDREN

🧪 Formulation Notes

2400mg ZMA(R) 750mg Tribulus Terrestris 50mg GABA PER DAILY SERVING

Additional Information

MANUFACTURED IN A GMP CERTIFIED FACILITY

{check} INFORMED CHOICE WWW.INFORMED-CHOICE.ORG

TruFacts(TM) FULL DISCLOSURE LABEL

v1.0

GLUTEN FREE

COR-PERFORMANCE SERIES

Woodbolt(TM) INTERNATIONAL

Product Details

UPC / SKU 6 32964 30430 8
DSLD Entry Date 2013-03-25
Product Type Other Combinations
Form Capsule
Brand Cellucor
DSLD ID 18932
Data Updated 2026-04-11

Research Evidence

291 Research Sources
55 Avg Quality Score
129 Meta Analysis
93 Systematic Review
51 Rct
11 Clinical Trial
2 Other
2 Regulatory Source
1 Openfda Safety
A Interventions for preventing delirium in hospitalised non-ICU patients
Meta Analysis The Cochrane database of systematic reviews 2016
A Melatonin for preoperative and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2020
A Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2022
B Pharmacological interventions for prevention of weight gain in people with schizophrenia
Meta Analysis The Cochrane database of systematic reviews 2022
B Melatonin for pre- and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2015
B Prevention of depression in adults with long-term physical conditions
Meta Analysis The Cochrane database of systematic reviews 2021
B Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis
Systematic Review Lancet (London, England) 2022
B Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis
Meta Analysis BMJ open 2023
B Second-generation antidepressants for preventing seasonal affective disorder in adults
Meta Analysis The Cochrane database of systematic reviews 2015
B Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries
Meta Analysis The Cochrane database of systematic reviews 2021
View all evidence for Melatonin →

Compare Similar Products

View all Melatonin products →